Antitrust

Pharmalot

Johnson & Johnson is fined $30 million for thwarting generics in France

By Ed Silverman

Pharmalot

FTC probes Mylan for possible antitrust violations involving EpiPen

By Ed Silverman

Pharmalot

Drug makers are sued for scheming to illegally fix insulin prices

By Ed Silverman

Pharmalot

Two former pharma execs first to be charged in generic price-fixing probe

By Ed Silverman

Pharmalot

Pharmalot, Pharmalittle: FTC is ‘aware’ of concerns over possible Mylan antitrust violations

By Ed Silverman

Pharmalot

Lawmakers call for FTC probe into potential antitrust violations in EpiPen school program

By Ed Silverman

Pharmalot

Supreme Court lets pay-to-delay ruling against pharma stand

By Ed Silverman

Pharmalot

FTC seeks review of a court ruling on generic drug competition

By Ed Silverman

Pharmalot

Drug maker fined for shorting supplies of cancer drugs in order to raise prices

By Ed Silverman

Pharmalot

Senator urges FTC to step up investigation into maker of addiction treatment

By Ed Silverman

Pharmalot

Drug maker loses appeal of antitrust pay-to-delay case in Europe

By Ed Silverman

Exclusive

Mylan may have violated antitrust law in its EpiPen sales to schools, legal experts say

By Ike Swetlitz and Ed Silverman

Pharmalot

Glaxo, other drug makers appeal UK fines for pay-to-delay deals

By Ed Silverman

Pharmalot

Pfizer fined by UK regulator amid pricing probe

By Ed Silverman

Lawmakers ask FTC to scrutinize pharma mergers over antitrust concerns

Pharmalittle: Opioid settlements may yield tax breaks for drug makers; EMA probes heartburn meds for carcinogens

Consumer groups and unions urge FTC to block AbbVie and Allergan merger

Generic drug price-fixing suit is akin to earlier case, but ‘on steroids,’ Conn. prosecutor says

Johnson & Johnson is fined $30 million for thwarting generics in France

FTC probes Mylan for possible antitrust violations involving EpiPen

Drug makers are sued for scheming to illegally fix insulin prices

Two former pharma execs first to be charged in generic price-fixing probe

Pharmalot, Pharmalittle: FTC is ‘aware’ of concerns over possible Mylan antitrust violations

Lawmakers call for FTC probe into potential antitrust violations in EpiPen school program

Supreme Court lets pay-to-delay ruling against pharma stand

FTC seeks review of a court ruling on generic drug competition

Drug maker fined for shorting supplies of cancer drugs in order to raise prices

Senator urges FTC to step up investigation into maker of addiction treatment

Drug maker loses appeal of antitrust pay-to-delay case in Europe

Mylan may have violated antitrust law in its EpiPen sales to schools, legal experts say

Glaxo, other drug makers appeal UK fines for pay-to-delay deals

Pfizer fined by UK regulator amid pricing probe